Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $0.10, $0.06 better than the analyst estimate of $0.04. Revenue for the quarter came in at $79.8 million versus the consensus estimate of $76.2 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.